Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

bivalirudin for injection - ADD-VANTAGE How Supplied/Storage and Handling


16.1 How Supplied

Bivalirudin for Injection is supplied as a sterile, lyophilized powder in single-dose, ADD-Vantage™ vials. Each vial contains 250 mg of bivalirudin equivalent to an average of 275 mg of bivalirudin trifluoroacetate.3

Unit of SaleConcentration
NDC 0409-8300-15
Tray containing 10 Single-dose ADD-Vantage™ vials
250 mg/vial

The range of bivalirudin trifluoroacetate is 270 to 280 mg based on a range of trifluoroacetic acid composition of 1.7 to 2.6 equivalents.

16.2 Storage

Store Bivalirudin for Injection dosage units at 20 to 25ºC (68 to 77ºF). [See USP Controlled Room Temperature.]

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event